{
  "docId": "019de071-eb84-776b-8e7d-ce40a476afec",
  "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02",
  "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 105,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-chart style layout to show the progression of various drug programs from discovery through clinical phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/12",
  "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec",
  "deckJsonHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec.json",
  "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.1,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "*Option to participate equally in the development and commercialization of Sanofi-partnered programs in the US",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17c8524b-10dc-42a2-b7b4-dfd17bdfa8d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.65,
        "y": 0.9
      },
      "kind": "legend",
      "text": "Oncology (dark blue) and Immunology-Inflammation (orange) color coding.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a5abd3f-0cf3-4842-8ba0-1692823718b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.78,
        "w": 0.94,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "table",
      "text": "Pipeline table showing Pathway, Program, Indication, Discovery, IND Enabling, Phase 1, Phases 2/3, Next Milestone, and Rights.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9282a1a0-8e5e-440b-8c8b-316d3485c963",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.62,
        "x": 0.19,
        "y": 0.04
      },
      "kind": "title",
      "text": "Kymera’s Pipeline of Novel Protein Degraders",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1fd488c-8cc6-41c0-82e5-ce0819913542",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "f08a0e00-3d2f-4eb6-a72a-22513c1f1678",
      "evidence": "The pipeline is structured as a timeline-based progress chart across development stages.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 11,
      "beatId": "86cb8a6d-db8c-40e2-814e-5bc67b50c2e5",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "The deck showcases Kymera's pipeline, clinical trials, and potential for broad activity across diseases, creating a desire for the solution.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "7d2f21f7-c191-4e6f-8cc3-d5255feabd13",
      "evidence": "The deck presents a series of slides explaining the problem, complication, and solution, forming a logic chain.",
      "position": 0,
      "objective": "To demonstrate the logic behind Kymera's TPD approach and its potential to expand the druggable proteome.",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}